Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013;86(3):177-80.
Epub 2013 Aug 5.

Immunosuppression in kidney transplantation

Adriana Muntean  1 , Mihai Lucan  1
Affiliations
Review

Immunosuppression in kidney transplantation

Adriana Muntean et al. Clujul Med. 2013.

Abstract

For most patients with chronic kidney failure, kidney transplantation has the greatest potential for restoring a healthy and productive life. The risk of acute rejection is the highest in the first months after transplantation (induction phase) and diminishes afterwards (maintenance phase). Immunosuppression should be at the highest level in the early period and reduced for long-term therapy. At present, conventional immunosuppressive protocols consist of the triple therapy: a calcineurin inhibitor, an adjunctive agent, corticosteroids. The development of new immunosuppressives drugs is aimed not only at improving short-term outcomes, but also achieving better safety, less nephrotoxicity and minimal side effects.

Keywords: immunosuppression; induction therapy; kidney transplantation; maintenance therapy.

PubMed Disclaimer

References

    1. Ponticelli C, Tarantino A, Vegeto A. Renal transplantation, past, present and future. J Nephrol. 1999;12( Suppl 2):S105–110. - PubMed
    1. Mahmud N, Klipa D, Ahsan N. Antibody immunosuppressive therapy in solid-organ transplant: Part I. MAbs. 2010;2(2):148–156. - PMC - PubMed
    1. Knight SR, Russell NK, Barcena L, Morris PJ. Mycophenolate mofetil decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review. Transplantation. 2009;87(6):785–794. - PubMed
    1. Gourishankar S, Turner P, Halloran P. New developments in immunosuppressive therapy in renal transplantation. Expert Opin Biol Ther. 2002;2(5):483–501. - PubMed
    1. Meier-Kriesche HU, Li S, Gruessner RW, et al. Immunosuppression: evolution in practice and trends, 1994–2004. Am J Transplant. 2006;6(5 Pt 2):1111–1131. - PubMed

LinkOut - more resources